Ignite Creation Date:
2026-03-26 @ 3:21 PM
Ignite Modification Date:
2026-04-23 @ 11:09 PM
Study NCT ID:
NCT02499627
Status:
TERMINATED
Last Update Posted:
2021-05-27
First Post:
2015-07-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bendamustine Plus Brentuximab Vedotin in HL and CD30+ PTCL in First Salvage Setting
Sponsor:
Fondazione Italiana Linfomi - ETS
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12-23
Start Date Type:
ACTUAL
Primary Completion Date:
2019-09-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-06-30
Completion Date Type:
ACTUAL
First Submit Date:
2015-07-14
First Submit QC Date:
None
Study First Post Date:
2015-07-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-26
Last Update Post Date:
2021-05-27
Last Update Post Date Type:
ACTUAL